CCIA
GMAB icon

Campbell & Co Investment Adviser’s Genmab GMAB Stock Holding History

Campbell & Co Investment Adviser’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-107,217
Closed -$2.22M – 1205
2025
Q2 		$2.22M Buy
107,217
+79,945
+293% +$1.64M 0.14% 222
2025
Q1 		$534K Buy
27,272
+14,399
+112% +$302K 0.04% 655
2024
Q4 		$269K Buy
+12,873
New +$283K 0.02% 879
2024
Q1 		– Sell
-59,003
Closed -$1.88M – 1213
2023
Q4 		$1.88M Buy
+59,003
New +$1.85M 0.17% 152
2023
Q3 		– Sell
-15,804
Closed -$601K – 1035
2023
Q2 		$601K Sell
15,804
-11,339
-42% -$452K 0.11% 340
2023
Q1 		$1.02M Sell
27,143
-15,708
-37% -$604K 0.19% 148
2022
Q4 		$1.82M Buy
42,851
+31,291
+271% +$1.29M 0.43% 13
2022
Q3 		$371K Sell
11,560
-4,416
-28% -$155K 0.08% 411
2022
Q2 		$519K Sell
15,976
-8,996
-36% -$291K 0.14% 263
2022
Q1 		$903K Buy
+24,972
New +$857K 0.24% 94
2021
Q4 		– Sell
-8,350
Closed -$365K – 682
2021
Q3 		$365K Buy
8,350
+2,200
+36% +$98.8K 0.12% 311
2021
Q2 		$251K Buy
+6,150
New +$237K 0.1% 377

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Campbell & Co Investment Adviser's GMAB Position: Q3 2025 in Review

Campbell & Co Investment Adviser sold out of Genmab (GMAB) in Q3 2025, closing a stake of 107,217 shares — an estimated $2.22M sold.

Campbell & Co Investment Adviser first reported a position in GMAB in Q2 2021 and held it in 12 quarters. The position peaked at $2.22M in Q2 2025. 252 funds tracked by Wall St. Rank hold GMAB as of Q3 2025.

  • Campbell & Co Investment Adviser reported no remaining Genmab position as of Q3 2025 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 107,217 Genmab shares in Q3 2025, an estimated $2.22M.
  • Campbell & Co Investment Adviser first reported a position in Genmab in Q2 2021 and held it in 12 quarters.
  • Campbell & Co Investment Adviser's Genmab position peaked at $2.22M in Q2 2025.
  • 252 funds tracked by Wall St. Rank held Genmab as of Q3 2025.

Based on Campbell & Co Investment Adviser's 13F filing for Q3 2025, filed 28 Oct 2025.